Boston Scientific Corp. (NYSE:BSX) sued Cook Group, a slew of its subsidiaries and a group of Korean firms, alleging infringement of four endoscopic stent patents covering devices to treat the digestive system.
The lawsuit, filed in the U.S. District Court for Massachusetts, accuses Warsaw, Indiana-based Cook and the subsidiaries (including Cook Ireland Ltd.) of violating the quartet of patents with its Evolution stenting system, according to court documents.
The suit also accuses Korean firms Taewong Medical Co. Ltd., Standard Sci-Tech Inc. and Sewoon Medical Co. Inc., along with Alpharetta, Ga.-based EndoChoice Inc., of violating three of the patents. Taewong’s Niti-S system and Standard Sci-Tech’s Bonastent system are named in the suit.
The lawsuit seeks a jury trial, declarations of infringement, injunctions barring any further infringement, damages, pre- and post-judgment interest and legal fees.